RiverVest Ventures is a private equity general partner firm located in United States.
Genoa Pharmaceuticals, a Seattle-based biopharmaceutical company, raised $62m in Series A from F-Prime Capital Partners and others.
ALung Technologies, a developer and manufacturer of innovative lung assist devices, closed a $36m Series C round from Philips and others.
Developer of label-free biosensor assays firm Adarza BioSystems has raised $17m in Series C from RiverVest Venture Partners.
Read more news concerning RiverVest Ventures
A sampling of RiverVest Ventures portfolio companies:
View all of the investments in their portfolio
Registration is fast, free and easy
Already a member?